Closed claims data explained: Benefits, limitations and commercial use cases
Know what closed payer claims can reveal about patient journeys, treatment persistence and the...
The therapeutic market that you know is shaped by the healthcare data that you can see. But when critical medical, specialty, clinical or longitudinal signals are absent from that view, the picture (and the decisions based on it) is less clear. ...
Know what closed payer claims can reveal about patient journeys, treatment persistence and the...
Most teams planning a total cost of care or burden of illness study assume the cost data will be...
Know what open claims data can reveal and when it’s the right starting point for research Adding...
Know what others can’t about scaling AI Artificial intelligence is already embedded in how life...
The therapeutic market that you know is shaped by the healthcare data that you can see. But when...
Most life sciences teams don't have a data shortage. They have blind spots such as patients who...
Stress-testing a research question Every technology vendor claims their product works. The question...
The social determinants of health (SDoH) are a key component of understanding and delivering better...
Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (CNS)...
Launching a pharmaceutical marketing campaign takes months of planning, creative development and...
Know what closed payer claims can reveal about patient journeys, treatment persistence and the commercial opportunities behind the data A patient starts therapy. But what happens next? Do they persist, switch or discontinue? For commercial teams, und...